Cipla has acquired four brands, namely CPink, CDense, Productiv and Folinine, to further strengthen its presence in women’s health portfolio. These brands, previously marketed by Wanbury, have a market size of Rs 3,100 crore in India with sales value of Rs 59.6 crore.
The drug maker said the nutraceutical products, to be sold under the four umbrella brands, would address various health needs for conditions arising due to nutritional deficiencies or insufficiencies. These include supplements such as multivitamins, multimineral and antioxidants for adolescent girls, pregnant and lactating women, women going through menopause, and for male and female reproductive health.
Cpink is iron supplement. It contains Ferrous Ascorbate and L-Methylfolate.
Cdense Tablet is an essential body mineral, it ensures the adequate supply of calcium to bones.It contains Calcium Orotate.
Calcium Orotate is the only type of calcium that penetrate the cell membrane and deliver maximum health benefits to cellular processes. Calcium plays a very important role in the body. It is necessary for normal functioning of nerves, cells, muscle, and bone. If there is not enough calcium in the blood, then the body will take calcium from bones, thereby weakening bones.Thus intake of Calcium is necessary to keep the bones strong.
L-folinine contains L-Folinine Tablet contains L-methylfolate, Methylcobalamin, and Pyridoxal 5-phosphate. L-Folinine Tablet is positioned in Pregnancy & Lactation, Neurological Disorders and in Pre-Post natal weakness.
Productiv a also an admired brand in the industry. It is also belongs to nutritional supplement.